| Kimberly Diane Nance, APRN, BC, FNP | |
|
1706 Highway 71 N, Mena, AR 71953-8917 | |
| (479) 394-4800 | |
| (479) 394-4805 |
| Full Name | Kimberly Diane Nance |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 19 Years |
| Location | 1706 Highway 71 N, Mena, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174685465 | NPI | - | NPPES |
| 163849758 | Medicaid | AR | |
| A01937 | Other | AR | AR LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | A01937 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| National Park Medical Center | Hot springs, AR | Hospital |
| St Vincent Hot Springs | Hot springs, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| First Care Family Medicine-mena Pllc | 3375804784 | 10 |
| Healthstar Physicians Of Hot Springs, Pllc | 5698665685 | 50 |
News Archive
The brains of Alzheimer patients have high accumulations of the material beta-amyloid, which appear in the form of plaques. The precursors of these plaques are believed to be the underlying cause of the nerve cell loss that leads to the disruptions in memory that characterize Alzheimer's disease. The main aim of many Alzheimer therapies is therefore to inhibit the formation of beta-amyloid. Since beta-amyloid is cleaved from the so-called amyloid precursor protein (APP), scientists have focused on stopping the two enzymes that attack the precursor protein. These act like molecular scissors and cut out the beta-amyloid fragment. Blocking these scissors precludes the formation of beta-amyloid.
BioDelivery Sciences International, Inc. today announced the enrollment and dosing of the first patient in its Phase 3 clinical program evaluating the efficacy and safety of BEMA Buprenorphine for the treatment of moderate to severe chronic pain.
In the United States, income inequality has steadily increased over the last several decades. Given widening inequities, health care leaders have been concerned about the health outcomes of older Americans who experience poverty, particularly because prior studies have shown a strong link between socioeconomic status and health.
The Angelman Syndrome Foundation further solidified its dedication to research by increasing its grant award total to more than $1 million for 2009. Most recently, more than $988,000 in grants was awarded to six principle investigators, focusing on Angelman Syndrome (AS) research.
Physicians targeting lung tumors for radiation therapy can substantially improve their aim by combining data from two scanning techniques, according to Washington University researchers at Siteman Cancer Center and Barnes-Jewish Hospital in St. Louis.
› Verified 1 days ago
| Entity Name | Healthstar Physicians Of Hot Springs, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821176934 PECOS PAC ID: 5698665685 Enrollment ID: O20040315001542 |
News Archive
The brains of Alzheimer patients have high accumulations of the material beta-amyloid, which appear in the form of plaques. The precursors of these plaques are believed to be the underlying cause of the nerve cell loss that leads to the disruptions in memory that characterize Alzheimer's disease. The main aim of many Alzheimer therapies is therefore to inhibit the formation of beta-amyloid. Since beta-amyloid is cleaved from the so-called amyloid precursor protein (APP), scientists have focused on stopping the two enzymes that attack the precursor protein. These act like molecular scissors and cut out the beta-amyloid fragment. Blocking these scissors precludes the formation of beta-amyloid.
BioDelivery Sciences International, Inc. today announced the enrollment and dosing of the first patient in its Phase 3 clinical program evaluating the efficacy and safety of BEMA Buprenorphine for the treatment of moderate to severe chronic pain.
In the United States, income inequality has steadily increased over the last several decades. Given widening inequities, health care leaders have been concerned about the health outcomes of older Americans who experience poverty, particularly because prior studies have shown a strong link between socioeconomic status and health.
The Angelman Syndrome Foundation further solidified its dedication to research by increasing its grant award total to more than $1 million for 2009. Most recently, more than $988,000 in grants was awarded to six principle investigators, focusing on Angelman Syndrome (AS) research.
Physicians targeting lung tumors for radiation therapy can substantially improve their aim by combining data from two scanning techniques, according to Washington University researchers at Siteman Cancer Center and Barnes-Jewish Hospital in St. Louis.
› Verified 1 days ago
| Entity Name | First Care Family Medicine-mena Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619410040 PECOS PAC ID: 3375804784 Enrollment ID: O20180228000200 |
News Archive
The brains of Alzheimer patients have high accumulations of the material beta-amyloid, which appear in the form of plaques. The precursors of these plaques are believed to be the underlying cause of the nerve cell loss that leads to the disruptions in memory that characterize Alzheimer's disease. The main aim of many Alzheimer therapies is therefore to inhibit the formation of beta-amyloid. Since beta-amyloid is cleaved from the so-called amyloid precursor protein (APP), scientists have focused on stopping the two enzymes that attack the precursor protein. These act like molecular scissors and cut out the beta-amyloid fragment. Blocking these scissors precludes the formation of beta-amyloid.
BioDelivery Sciences International, Inc. today announced the enrollment and dosing of the first patient in its Phase 3 clinical program evaluating the efficacy and safety of BEMA Buprenorphine for the treatment of moderate to severe chronic pain.
In the United States, income inequality has steadily increased over the last several decades. Given widening inequities, health care leaders have been concerned about the health outcomes of older Americans who experience poverty, particularly because prior studies have shown a strong link between socioeconomic status and health.
The Angelman Syndrome Foundation further solidified its dedication to research by increasing its grant award total to more than $1 million for 2009. Most recently, more than $988,000 in grants was awarded to six principle investigators, focusing on Angelman Syndrome (AS) research.
Physicians targeting lung tumors for radiation therapy can substantially improve their aim by combining data from two scanning techniques, according to Washington University researchers at Siteman Cancer Center and Barnes-Jewish Hospital in St. Louis.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kimberly Diane Nance, APRN, BC, FNP 1706 Highway 71 N, Mena, AR 71953-8917 Ph: (479) 394-4800 | Kimberly Diane Nance, APRN, BC, FNP 1706 Highway 71 N, Mena, AR 71953-8917 Ph: (479) 394-4800 |
News Archive
The brains of Alzheimer patients have high accumulations of the material beta-amyloid, which appear in the form of plaques. The precursors of these plaques are believed to be the underlying cause of the nerve cell loss that leads to the disruptions in memory that characterize Alzheimer's disease. The main aim of many Alzheimer therapies is therefore to inhibit the formation of beta-amyloid. Since beta-amyloid is cleaved from the so-called amyloid precursor protein (APP), scientists have focused on stopping the two enzymes that attack the precursor protein. These act like molecular scissors and cut out the beta-amyloid fragment. Blocking these scissors precludes the formation of beta-amyloid.
BioDelivery Sciences International, Inc. today announced the enrollment and dosing of the first patient in its Phase 3 clinical program evaluating the efficacy and safety of BEMA Buprenorphine for the treatment of moderate to severe chronic pain.
In the United States, income inequality has steadily increased over the last several decades. Given widening inequities, health care leaders have been concerned about the health outcomes of older Americans who experience poverty, particularly because prior studies have shown a strong link between socioeconomic status and health.
The Angelman Syndrome Foundation further solidified its dedication to research by increasing its grant award total to more than $1 million for 2009. Most recently, more than $988,000 in grants was awarded to six principle investigators, focusing on Angelman Syndrome (AS) research.
Physicians targeting lung tumors for radiation therapy can substantially improve their aim by combining data from two scanning techniques, according to Washington University researchers at Siteman Cancer Center and Barnes-Jewish Hospital in St. Louis.
› Verified 1 days ago
Terri L Barrada, CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 136 Health Park Dr, Mena, AR 71953 Phone: 888-710-8220 Fax: 866-573-0761 | |
Gretchen Laurel Goodnight, ANP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 403 Morrow St N Ste D, Mena, AR 71953 Phone: 479-437-6080 Fax: 479-437-6079 | |
Lindy Kaye Jumper, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 136 Health Park Dr, Mena, AR 71953 Phone: 888-710-8220 Fax: 866-573-0761 | |
Ocean Miranda Brewer, APRN-CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1210 Dequeen St, Mena, AR 71953 Phone: 479-394-5068 Fax: 479-394-5626 | |
Sandy Morgan, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1706 Highway 71 N, Mena, AR 71953 Phone: 479-394-1500 Fax: 479-394-1525 | |
Mrs. Debra Inevia Fairless, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1210 Dequeen St, Mena, AR 71953 Phone: 479-394-5068 Fax: 479-394-5626 |